These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 10860738)
1. Co-evolution of proteins with their interaction partners. Goh CS; Bogan AA; Joachimiak M; Walther D; Cohen FE J Mol Biol; 2000 Jun; 299(2):283-93. PubMed ID: 10860738 [TBL] [Abstract][Full Text] [Related]
2. Codep: maximizing co-evolutionary interdependencies to discover interacting proteins. Tillier ER; Biro L; Li G; Tillo D Proteins; 2006 Jun; 63(4):822-31. PubMed ID: 16634043 [TBL] [Abstract][Full Text] [Related]
3. Chapter 12. The use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists. Carter PH; Tebben AJ Methods Enzymol; 2009; 461():249-79. PubMed ID: 19480923 [TBL] [Abstract][Full Text] [Related]
4. Correlation between conformational stability of the ternary enzyme-substrate complex and domain closure of 3-phosphoglycerate kinase. Varga A; Flachner B; Gráczer E; Osváth S; Szilágyi AN; Vas M FEBS J; 2005 Apr; 272(8):1867-85. PubMed ID: 15819882 [TBL] [Abstract][Full Text] [Related]
5. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding. Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073 [TBL] [Abstract][Full Text] [Related]
6. Substrate binding modifies the hinge bending characteristics of human 3-phosphoglycerate kinase: a molecular dynamics study. Palmai Z; Chaloin L; Lionne C; Fidy J; Perahia D; Balog E Proteins; 2009 Nov; 77(2):319-29. PubMed ID: 19422062 [TBL] [Abstract][Full Text] [Related]
7. A 1.8 A resolution structure of pig muscle 3-phosphoglycerate kinase with bound MgADP and 3-phosphoglycerate in open conformation: new insight into the role of the nucleotide in domain closure. Szilágyi AN; Ghosh M; Garman E; Vas M J Mol Biol; 2001 Feb; 306(3):499-511. PubMed ID: 11178909 [TBL] [Abstract][Full Text] [Related]
8. Evolution of the Class 2 cytokines and receptors, and discovery of new friends and relatives. Krause CD; Pestka S Pharmacol Ther; 2005 Jun; 106(3):299-346. PubMed ID: 15922016 [TBL] [Abstract][Full Text] [Related]
10. The amino terminus and the third extracellular loop of CX3CR1 contain determinants critical for distinct receptor functions. Chen Y; Green SR; Almazan F; Quehenberger O Mol Pharmacol; 2006 Mar; 69(3):857-65. PubMed ID: 16317113 [TBL] [Abstract][Full Text] [Related]
11. Receptor oligomerization: a pivotal mechanism for regulating chemokine function. Muñoz LM; Lucas P; Holgado BL; Barroso R; Vega B; Rodríguez-Frade JM; Mellado M Pharmacol Ther; 2011 Sep; 131(3):351-8. PubMed ID: 21600920 [TBL] [Abstract][Full Text] [Related]
12. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies. Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150 [TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation. Xanthou G; Williams TJ; Pease JE Eur J Immunol; 2003 Oct; 33(10):2927-36. PubMed ID: 14515277 [TBL] [Abstract][Full Text] [Related]
17. Chemokine-binding specificity of soluble chemokine-receptor analogues: identification of interacting elements by chimera complementation. Datta-Mannan A; Stone MJ Biochemistry; 2004 Nov; 43(46):14602-11. PubMed ID: 15544331 [TBL] [Abstract][Full Text] [Related]
18. Determinants of high-affinity binding and receptor activation in the N-terminus of CCL-19 (MIP-3 beta). Ott TR; Lio FM; Olshefski D; Liu XJ; Struthers RS; Ling N Biochemistry; 2004 Mar; 43(12):3670-8. PubMed ID: 15035637 [TBL] [Abstract][Full Text] [Related]